Table 1.
Characteristics of patients included in the immunohistochemistry study
| Variables | AD (n = 25) |
|---|---|
| Age at death (years) | |
| Median [IQR] | 81.0 [73.0–87.0] |
| Range | 59.0–96.0 |
| Female gender, n (%) | 18 (72) |
| Post mosterm interval | |
| Median [IQR] | 21.0 [9.0–27.0] |
| Range | 3.0–96.0 |
| “A” Thal - n of patients (%) | |
| 3 (4 and 5) | 21 (84) |
| 2 (3) | 3 (12) |
| 1 (1 and 2) | 1 (4) |
| 0 (None) | 0 (0) |
| “B” Braak Stage - n of patients (%) | |
| 3 (V and VI) | 24 (96) |
| 2 (III and IV) | 1 (4) |
| 1 (I and II) | 0 (0) |
| 0 (None) | 0 (0) |